NATCO Pharma informs about press release

25 Jul 2022 Evaluate

NATCO Pharma has informed that it enclosed the press release today titled ‘NATCO Announces Approval of its ANDA for Cabazitaxel Intravenous Solution (generic for Jevtana Kit®)’ under Regulation 30 of SEBI (LODR) Regulations 2015 for the information.

The above information is a part of company’s filings submitted to BSE.

Natco Pharma Share Price

897.05 1.15 (0.13%)
30-Dec-2025 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1720.80
Dr. Reddys Lab 1265.95
Cipla 1491.40
Zydus Lifesciences 902.30
Lupin 2081.00
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×